News & Events

In a recent article published by ‘Manufacturing Chemist‘, our CEO, Dr. Yuchen Zhou, provides a comprehensive insight into the obstacles impacting stem cell therapy research. A significant issue lies in the cell separation stage, often leading to lengthy preparation times

We’re delighted to share the launch of the CellQuest Grant for clinical research scientists specializing in multiple myeloma and cell therapy development. This initiative, open until mid-November 2023, grants the winning researcher access to the MARS® Bar cell separation system

We are thrilled to share the news that Applied Cells has officially become a member of MassBio! MassBio, the Massachusetts Biotechnology Council, is driven by a powerful mission: to propel Massachusetts to the forefront of life sciences leadership, fostering industry

Santa Clara, California – We are thrilled to announce that MARS® Bar is among the Winners of The Scientist’s Top 10 Innovations of 2022! Each year The Scientist highlights the latest and greatest tools, technologies, and techniques to hit the

Santa Clara, California, and Piscataway, New Jersey – November 18th, 2022. Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide. Under this collaboration, GenScript will

Santa Clara, California, and Vancouver, Canada – April 19, 2022. Applied Cells Inc. and STEMCELL Technologies Canada Inc. have announced their collaboration to deliver a new high-performance cell separation solution that combines Applied Cells’ MARS® platform with STEMCELL’s EasySep™ immunomagnetic